Skip to main content
    C

    Cigna Corp (CI)

    Official site

    HEALTHCARE • HEALTHCARE PLANS • NYSE

    $305.88
    -1.07 (-0.35%)

    Market Cap: $80.80B

    Last updated: Oct 27, 2026 at 4:38 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    92%(36/39)
    Avg Surprise
    +6.17%
    Streak
    6 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$7.51
    Range$7.42 - $7.71
    23 analysts
    EPS Revisions
    1
    0
    7d
    2
    2
    30d
    EPS Estimate DriftChange to current
    90d ago$7.62-1.4%
    60d ago$7.50+0.2%
    30d ago$7.49+0.2%
    7d ago$7.51+0.0%
    Current$7.51
    Revenue Consensus
    $72.4B
    Range$70.5B - $74.3B
    13 analysts
    Period ending Dec 31, 2026
    EPS Consensus$7.80
    Range$7.73 - $8.00
    24 analysts
    Revenue Consensus
    $78.6B
    Range$72.7B - $85.1B
    16 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$7.80---
    Sep 26EST
    		-$7.51---
    Jun 26
    Reported Jul 30
    		$7.78$7.58+2.64%Beat+8.1%
    Mar 26
    Reported Apr 30
    		$7.79$7.61+2.37%Beat+15.6%
    Dec 25
    Reported Feb 5
    		$8.08$7.88+2.54%Beat+21.7%
    Sep 25
    Reported Oct 30
    		$7.83$7.64+2.49%Beat+4.3%
    Jun 25
    Reported Jul 31
    		$7.20$7.15+0.70%Beat+7.1%
    Mar 25
    Reported May 2
    		$6.74$6.35+6.14%Beat+4.2%
    Dec 24
    Reported Jan 30
    		$6.64$7.82-15.09%Miss-2.2%
    Sep 24
    Reported Oct 31
    		$7.51$7.25+3.59%Beat+10.9%
    Jun 24
    Reported Aug 1
    		$6.72$6.42+4.67%Beat+9.6%
    Mar 24
    Reported May 1
    		$6.47$6.22+4.02%Beat+19.6%
    Dec 23
    Reported Feb 2
    		$6.79$6.54+3.82%Beat+36.9%
    Sep 23
    Reported Nov 2
    		$6.77$6.68+1.35%Beat+12.1%
    Jun 23
    Reported Aug 3
    		$6.13$6.04+1.49%Beat-1.4%
    Mar 23
    Reported May 5
    		$5.41$5.24+3.24%Beat-10.0%
    Dec 22
    Reported Feb 3
    		$4.96$4.87+1.85%Beat+4.0%
    Sep 22
    Reported Nov 3
    		$6.04$5.71+5.78%Beat+5.4%
    Jun 22
    Reported Aug 4
    		$6.22$5.49+13.30%Beat+18.7%
    Mar 22
    Reported May 6
    		$6.01$5.18+16.02%Beat+27.1%
    Dec 21
    Reported Feb 3
    		$4.77$4.71+1.27%Beat+35.9%
    Sep 21
    Reported Nov 4
    		$5.73$5.21+9.98%Beat+29.9%
    Jun 21
    Reported Aug 5
    		$5.24$4.97+5.43%Beat-9.8%
    Mar 21
    Reported May 7
    		$4.73$4.40+7.50%Beat+0.9%
    Dec 20
    Reported Feb 4
    		$3.51$3.69-4.88%Miss-18.6%
    Sep 20
    Reported Nov 5
    		$4.41$4.23+4.26%Beat-2.9%
    Jun 20
    Reported Jul 30
    		$5.81$5.16+12.60%Beat+35.1%
    Mar 20
    Reported Apr 30
    		$4.69$4.36+7.57%Beat+20.3%
    Dec 19
    Reported Feb 6
    		$4.31$4.20+2.62%Beat+75.2%
    Sep 19
    Reported Oct 31
    		$4.54$4.36+4.13%Beat+18.2%
    Jun 19
    Reported Aug 1
    		$4.30$3.74+14.97%Beat+10.5%
    Mar 19
    Reported May 2
    		$3.90$3.73+4.56%Beat-5.1%
    Dec 18
    Reported Feb 1
    		$2.46$2.49-1.20%Miss+26.8%
    Sep 18
    Reported Nov 1
    		$3.84$3.44+11.63%Beat+35.7%
    Jun 18
    Reported Aug 2
    		$3.89$3.33+16.82%Beat+33.7%
    Mar 18
    Reported May 3
    		$4.11$3.39+21.24%Beat+48.4%
    Dec 17
    Reported Feb 1
    		$1.94$1.87+3.74%Beat+3.7%
    Sep 17
    Reported Nov 2
    		$2.83$2.36+19.92%Beat-
    Jun 17
    Reported Aug 4
    		$2.91$2.48+17.34%Beat-
    Mar 17
    Reported May 5
    		$2.77$2.46+12.60%Beat-
    Dec 16
    Reported Feb 2
    		$1.87$1.74+7.47%Beat-

    Dividends

    Dividend Metrics

    Forward Yield2.04%
    Forward Annual Dividend$6.24
    Payout Ratio15.92%
    FrequencyQuarterly
    Pay MonthsMar, Jun, Sep, Dec

    Growth

    3Y CAGR+10.47%
    5Y CAGR+172.77%
    CI dividend history and ex-dividend datesRun CI in the free DRIP calculator

    Key Metrics

    Valuation
    P/E Ratio9.72EV/EBITDA11.71x
    Price/FCF8.87xFCF Yield11.27%
    Profitability
    Profit Margin2.27%Operating Margin3.99%
    ROE16.80%ROIC6.90%
    Financial Health
    Debt/Equity1.76xInterest CoverageN/A
    Current RatioN/AQuick RatioN/A
    Trading Statistics
    Beta0.30Avg Volume1.62M
    52-Week High$316.2652-Week Low$234.20

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$301.14
    SMA 20$288.40
    SMA 50$281.75
    SMA 200$279.36
    EMA 10$301.06
    EMA 20$293.35
    EMA 50$285.68
    EMA 200$283.01

    MACD

    Line: 8.51Signal: 6.02Hist: 2.49

    ADX

    ADX: 26.5+DI: 29.9-DI: 10.8

    Aroon & PSAR

    Aroon Up92.0
    Aroon Down32.0
    PSAR$298.22

    Bollinger Bands

    Upper Band$318.55
    Lower Band$258.25
    %B Position2091%(Upper)
    Band Width0.79

    RSI (14-Day)

    Neutral
    63.8

    Momentum Oscillators

    Stoch %K84.7
    Stoch %D91.0
    Williams %R-25.0
    ROC (10d)8.0%
    Momentum22.55
    CCI (20d)96.3
    MFI (14d)64.5

    Volatility Measures

    ATR (14d)$7.58(2.5%)
    StdDev (20d)15.08
    Hist Vol26.6%(Moderate)

    Volume Flow

    VWAP$307.09
    OBV-18.9M
    AD Line-434.5M
    CMF (20d)0.202

    Volume Metrics

    Avg Vol (20d)1.6M
    Vol Ratio1.1x
    VWMA (20d)$287.51

    Pivot Points

    R3$323.72
    R2$319.79
    R1$313.37
    Pivot Point$309.44
    S1$303.02
    S2$299.09
    S3$292.67

    Advanced Oscillators

    TSI31.64
    Ultimate Osc57.5
    KST81.26

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$71.61B$68.76B$72.30B$69.81B$67.23B$65.54B$64.01B$62.69B$60.48B$57.24B$49.60B$49.01B
    Cost of RevenueN/A$62.02B$66.92B$63.81B$59.34B$58.90B$59.19B$57.09B$54.01B$50.87B$44.54B$42.57B
    Gross ProfitN/A$6.47B$5.55B$5.94B$7.89B$6.61B$6.46B$6.60B$6.52B$6.38B$6.57B$6.48B
    Operating Expenses$68.99B$66.14B$70.13B$67.17B$64.87B$63.53B$61.64B$61.12B$58.11B$56.84B$49.05B$46.81B
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$0$0$0$0$0$0$0$0$0$0$0$0
    Operating IncomeN/A$2.36B$2.15B$2.58B$2.43B$1.97B$2.17B$2.58B$2.41B$2.26B$2.06B$2.24B
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$0$0$335.00M$0$0$0$362.00M$0$0$0$360.00M$0
    Income Before Tax$2.26B$2.27B$1.82B$2.29B$2.02B$1.65B$2.01B$1.19B$1.99B$79.00M$188.00M$1.84B
    Income Tax Expense$382.00M$409.00M$543.00M$322.00M$389.00M$239.00M$473.00M$367.00M$360.00M$291.00M$-919,000,000$391.00M
    Net Income$1.88B$1.86B$1.27B$1.97B$1.63B$1.41B$1.54B$825.00M$1.63B$-212,000,000$1.11B$1.45B
    EBITDA$3.27B$3.28B$2.90B$3.34B$3.04B$2.68B$3.02B$2.22B$3.10B$1.14B$1.31B$2.97B
    EBIT$2.61B$2.63B$2.18B$2.64B$2.36B$2.01B$2.37B$1.57B$2.36B$401.00M$548.00M$2.21B
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    I Tested One Of Wall Street’s Favorite AI Trades - It Failed

    Travelers Q2 core income $10.04 vs $5.41 consensus, stock +10%; CEO credited AI for a 0.5 percentage-point improvement in underlying loss ratio while expense ratio rose to 29%. Wall Street thesis posits AI cuts SG&A to create EPS torque in low-margin giants - e.g....

    Leo Nelissen
    •
    8/2/26
    •
    256
    AI Stocks
    Also mentions:
    TRVCVSKRWMTUNH

    News

    Cigna Group sets November 5 results date for Cigna Group stock

    Cigna Group has scheduled its third-quarter earnings release for November 5, 2026. The company reported second-quarter revenue of USD 71.70 billion and adjusted earnings per share of USD 7.78...

    ad-hoc-news.de•10/27/26•Neutral

    HCA Healthcare beats quarterly profit estimates on demand for medical services

    HCA Healthcare exceeded third-quarter profit estimates due to strong patient traffic and unexpected Medicaid supplemental payments...

    KELO-AM•10/27/26•Neutral

    Centene (CNC) Q3 Earnings and Revenues Surpass Estimates

    Centene (CNC) reported strong Q3 earnings of $0.58 per share, significantly beating the Zacks Consensus Estimate of $0.07, and revenues of $50.65 billion...

    Yahoo! Finance Canada•10/27/26•Somewhat-Bullish

    Piper Sandler reiterates USD 370 target for Cigna Group stock

    Piper Sandler has reiterated an Overweight rating and a USD 370.00 price target for Cigna Group stock, following the company's September strategy update. Cigna Group previously set adjusted EPS guidance of at least USD...

    ad-hoc-news.de•10/27/26•Somewhat-Bullish

    Centene exiting Hawaii’s Med-QUEST program at end of year

    National health insurer Centene is pulling its 'Ohana Health Plan out of Hawaii’s Med-QUEST Medicaid market, effective December 31, 2026, impacting 24,000 members. The company cited rising medical costs...

    The Garden Island•10/27/26•Neutral

    CI Valuation and Fair Value

    P/E
    9.7x
    Forward P/E
    9.1x
    EV/EBITDA
    11.7x
    P/FCF
    8.9x
    PEG
    0.8x
    P/B
    1.9x
    See GNG's fair value

    CI Profitability: Margins, ROIC and FCF

    Operating margin
    4.0%
    Net margin
    2.3%
    ROIC
    6.9%
    ROE
    16.8%
    FCF yield
    11.3%

    CI Competitors

    CompanyTicker
    Regeneron Pharmaceuticals IncREGN
    Moderna IncMRNA
    Elevance Health IncELV
    Boston Scientific CorpBSX
    Sanofi ADRSNY
    Takeda Pharmaceutical Co Ltd ADRTAK
    HCA Healthcare, Inc.HCA
    Cencora Inc.COR

    Sector: Healthcare

    CI Analyst Ratings

    Consensus
    Buy
    Analysts
    24
    Strong Buy
    6
    Buy
    12
    Hold
    6
    Sell
    0
    Strong Sell
    0

    CI Bull Case vs Bear Case

    Bull case

    • CI beat EPS estimates in 87.5% of its last 8 reported quarters.
    • 75.0% of CI's analyst ratings are Buy or Strong Buy.

    CI Earnings: Beat Rate and Next Report

    Beat rate
    7 of 8 quarters (87.5%)
    Average surprise
    0.7%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $7.51
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    2 up, 2 down

    CI Dividend

    Forward yield
    2.0%
    Payout ratio
    15.9%
    3Y DPS growth
    10.5%
    5Y DPS growth
    172.8%
    Pay months
    Mar, Jun, Sep, Dec
    CI dividend history

    Frequently Asked Questions About CI

    What is CI's current dividend yield?

    Cigna Corp (CI) has a forward dividend yield of 2.04%.

    Does CI pay dividends?

    Yes, Cigna Corp pays dividends with a forward dividend yield of 2.04%.

    What is CI's P/E ratio?

    Cigna Corp has a price-to-earnings (P/E) ratio of 9.72.

    What is CI's market cap?

    Cigna Corp (CI) has a market capitalization of $80.80B with a current stock price of $305.88.

    Related stocks

    Sector: Healthcare

    All stocks starting with C

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In